Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3490560 Title: NIRAPARIB POUR SON UTILISATION DANS UNE MÉTHODE DE TRAITEMENT DU CANCER DE LA PROSTATE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
177542263
WO application number:
US2017044413
Type:
European patent granted for BE
Status:
Open
Publication number:
3490560
WO publication number:
WO2018023017
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
2025C/531

Dates

Filing date:
28/07/2017
Grant date:
22/01/2025
EP publication date:
05/06/2019
WO publication date:
01/02/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/01/2025
EP B1 publication date:
22/01/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
28/07/2037

Applicant

Name:
Janssen Pharmaceutica, N.V.
Legal Form:
From:
22/01/2025
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
To:

Agent

Name:
NOVAGRAAF BREVETS
Legal Form:
From:
28/01/2025
Address:
Bâtiment O2 2 rue Sarah Bernhardt CS90017, 92665, Asnières-sur-Seine Cedex, France (FR)
To:

Inventor

1

Name:
GOTTARDIS, Marco
Legal Form:
Address:
Princeton New Jersey 08540, United States (US)

2

Name:
HAWKINS, Rebecca
Legal Form:
Address:
Spring House 19477, Panama (PA)

3

Name:
SNYDER, Linda
Legal Form:
Address:
Spring House Pennsylvania 19477, United States (US)

4

Name:
YAMADA, Douglas H.
Legal Form:
Address:
Spring House Pennsylvania 19477, United States (US)

Priority

1

Priority patent number:
201662369239 P
Priority date:
01/08/2016
Priority country:
United States (US)

2

Priority patent number:
201662368466 P
Priority date:
29/07/2016
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/454; A61P 35/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2025/02
Publication date:
21/03/2025
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202504
Publication date:
22/01/2025
Description:
Grant (B1)

2

Issue number:
202509
Publication date:
26/02/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
31/07/2026
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
19/06/2025
Last annual fee paid number:
9
Last annual fee paid amount:
165 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
28/01/2025 Incoming Correspondence (Post) 1 PDF /4/5/9/2/0/0722502954/docs/177542263_0_incomingcorrespondencepaper_20250128_101522467.pdf
07/02/2025 Incoming Correspondence (Post) 1 PDF /4/5/9/2/0/0722502954/docs/177542263_1_incomingcorrespondencepaper_20250207_105158140.pdf
29/01/2025 General Document Other 1 PDF /4/5/9/2/0/0722502954/docs/177542263_2_generaldocument_20250203_112040535.pdf